These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 905902)

  • 21. Rheumatoid arthritis: an immune complex disease? A review of the reaction of antigen with antibody to form immune complexes and the mechanisms by which they mediate tissue injury.
    Hester RB; Bennett JC
    Geriatrics; 1973 Jun; 28(6):84-91. PubMed ID: 4126064
    [No Abstract]   [Full Text] [Related]  

  • 22. Predominance of T-lymphocytes with a high-affinity receptor for sheep red blood cells in the synovial fluid of patients with rheumatoid arthritis. A short communication.
    Gramatzki M; Kalden JR
    Z Rheumatol; 1981; 40(1):21-4. PubMed ID: 6971545
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analyses of lymphocytes from patients with rheumatoid arthritis and systemic lupus erythematosus. Occurrence of interfering cold-reactive antilymphocyte antibodies.
    Winchester RJ; Winfield JB; Siegal F; Wernet P; Bentwich Z; Kunkel HG
    J Clin Invest; 1974 Nov; 54(5):1082-92. PubMed ID: 4138924
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical and pathogenetic patterns in chronic rheumatic inflammation].
    Nasonova VA
    Vestn Akad Med Nauk SSSR; 1979; (12):3-12. PubMed ID: 316238
    [No Abstract]   [Full Text] [Related]  

  • 25. [Immunologic study of synovial fluid. I. Investigation of the rheumatoid factor, intraleukocytic immunolobulins, antinuclear antibodies and anticonstitutents of the nucleus].
    Solnica J; Kahn MF; de Sèze S
    Rev Rhum Mal Osteoartic; 1968 Jun; 35(6):312-21. PubMed ID: 4178302
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical significance of synovial fluid total hemolytic complement activity.
    Kim HJ; McCarty DJ; Kozin F; Koethe S
    J Rheumatol; 1980; 7(2):143-52. PubMed ID: 7373616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibody-mediated lymphocytotoxicity in rheumatoid arthritis and systemic lupus erythematosus.
    Diaz-Jouanen E; Bankhurst AD; Williams RC
    Arthritis Rheum; 1976; 19(2):133-41. PubMed ID: 1083239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-antibody and other antiglobulin specificities in nonrheumatoid and rheumatoid effusion fluids and matched sera.
    Seward CW; Parker LP; Osterland CK
    J Lab Clin Med; 1974 Jan; 83(1):104-11. PubMed ID: 4543438
    [No Abstract]   [Full Text] [Related]  

  • 29. [Immunologic and ultrastructural analysis of lymphocytes in rheumatoid synovial fluid].
    Gabrielescu E; Stoicescu M; Codorean E; Niculescu D
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1985; 37(6):567-74. PubMed ID: 2871616
    [No Abstract]   [Full Text] [Related]  

  • 30. Studies on the nature of circulating DNA in systemic lupus erythematosus (SLE).
    Harbeck RJ; Hoffmann AA; Carr RI
    J Rheumatol; 1975 Jun; 2(2):194-203. PubMed ID: 125344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Inhibitory effect of sera from patients with rheumatic diseases on EA-rosette formation].
    Nasonov EL; Aleksandrova EN; Sura VV; Ivanova MM; Zimin IuI
    Ter Arkh; 1983; 55(7):32-7. PubMed ID: 6604958
    [No Abstract]   [Full Text] [Related]  

  • 32. Levels of SC5b--9 complement complex in plasma and synovial fluid of patients with rheumatic disease.
    Rus V; Malide D; Boloşiu HD; Parasca I; Duţu AL
    Med Interne; 1990; 28(4):305-10. PubMed ID: 2100875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Culture of lymphocytes in the presence of synovial fluid].
    Moens C
    Rev Rhum Mal Osteoartic; 1968 Dec; 35(12):642-4. PubMed ID: 5717213
    [No Abstract]   [Full Text] [Related]  

  • 34. Serum and synovial fluid inhibitors of antibody-mediated lymphocytotoxicity in rheumatoid arthritis and systemic lupus erythematosus.
    Arthritis Rheum; 1976; 19(2):142-9. PubMed ID: 56939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies of immune deposits in synovial membranes and corresponding synovial fluids.
    Brandt KD; Cathcart ES; Cohen AS
    J Lab Clin Med; 1968 Oct; 72(4):631-47. PubMed ID: 4175674
    [No Abstract]   [Full Text] [Related]  

  • 36. The use of T cell subtyping to distinguish rheumatoid arthritis from systemic lupus erythematosus.
    Traycoff RB; Rogers WW; Gregory SA
    J Rheumatol; 1981; 8(3):494-7. PubMed ID: 6974781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of Fc-rosette formation by synovial fluids from patients with rheumatoid arthritis.
    Hashimoto Y; Morito T; Tanimoto K; Horiuchi Y
    Ann Rheum Dis; 1977 Apr; 36(2):170-5. PubMed ID: 857743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies with human leukocyte lysosomes. Evidence for antilysosome antibodies in lupus erythematosus and for the presence of lysosomal antigen in inflammatory diseases.
    Bell DA; Thiem PA; Vaughan JH; Leddy JP
    J Clin Invest; 1975 Feb; 55(2):256-68. PubMed ID: 1092714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppression of Fc Receptor and C4.C3 receptors of the granulocytes from patients with systemic lupus erythematosus.
    Shingu M; Todoroki T; Sakai K; Nobunaga M
    J Rheumatol; 1981; 8(6):910-6. PubMed ID: 7328566
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating immunological complexes in the course of rheumatoid arthritis and systemic lupus erythematosus.
    Swierczyńska Z
    Mater Med Pol; 1981; 13(3):195-8. PubMed ID: 7345263
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.